COVID-19 Project Team: Difference between revisions
Jump to navigation
Jump to search
Jose Loyola (talk | contribs) |
|||
| (One intermediate revision by one other user not shown) | |||
| Line 31: | Line 31: | ||
'''Endocrinology and COVID-19''' | '''Endocrinology and COVID-19''' | ||
*'''[[User:Tayyaba Ali|Tayyaba Ali, M.D.]]''' | *'''[[User:Tayyaba Ali|Tayyaba Ali, M.D.]]''' | ||
* [[User:Anahita|Anahita Deilamsalehi, M.D.]] | |||
{{ColBreak}} | {{ColBreak}} | ||
'''Frequently Asked Inpatient Questions Team Members''' | '''Frequently Asked Inpatient Questions Team Members''' | ||
| Line 88: | Line 89: | ||
*[[User:Rina Ghorpade|Rina Ghorpade, M.B.B.S.]] | *[[User:Rina Ghorpade|Rina Ghorpade, M.B.B.S.]] | ||
*[[User:Rija Gul|Rija Gul, M.B.B.S]] | *[[User:Rija Gul|Rija Gul, M.B.B.S]] | ||
'''Infectious | '''Infectious Diseases and COVID-19''' | ||
* [[User:Zaida Obeidat|Zaida Obeidat, M.D.]] | * [[User:Zaida Obeidat|Zaida Obeidat, M.D.]] | ||
* [[User:Syed rizvi|Syed Rizvi, M.B.B.S.]] | * [[User:Syed rizvi|Syed Rizvi, M.B.B.S.]] | ||
'''[[COVID-19 | '''[[COVID-19 Medical Therapy]] | ||
* [[User:Sara Zand|Sara Zand, M.D.]] | * [[User:Sara Zand|Sara Zand, M.D.]] | ||
'''[[COVID-19 | '''[[COVID-19 Other Diagnostic Studies]] | ||
* [[User:Mandana Safakhah|Mandana Safakhah, M.D.]] | * [[User:Mandana Safakhah|Mandana Safakhah, M.D.]] | ||
'''[[COVID-19 Vaccines]]''' | |||
* [[User:Jose Loyola|José Eduardo Riceto Loyola Junior, M.D.]] | |||
Latest revision as of 01:27, 24 August 2021
| COVID-19 Project |
|---|
| Introduction |
| Team |
| Meetings' Summary |
| Topics |
| Ongoing Clinical Trials |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sahar Memar Montazerin, M.D.[2]
Meet The Team
Associate Editor(s)-in-Chief:
- The name of the leaders are written in bold: